Friday - March 13, 2026

Advanced Renal Cell Carcinoma Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Advanced Renal Cell Carcinoma Pipeline Insights 2026” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape. It covers the Advanced Renal Cell Carcinoma Pipeline drug profiles, including clinical and nonclinical … Continue reading

Brain Metastases Clinical Trial Pipeline Expands as 40+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Brain Metastases Pipeline Insights 2026” report provides comprehensive insights about 40+ Brain Metastases companies and 45+ pipeline drugs in Brain Metastases pipeline landscape. It covers the Brain Metastases pipeline drug profiles, including clinical and nonclinical stage products. Brain Metastases … Continue reading

Dividend Data Launches “Dividend Data for Spreadsheets,” Bringing 30+ Years of Dividend and Financial Data Directly to Excel and Google Sheets

The new spreadsheet add-in eliminates manual copy-paste research for investors and analysts, offering 16 formulas, 80,000+ supported tickers, and a permanent free tier. Dividend Data has officially announced the launch of Dividend Data for Spreadsheets, a free financial data add-in … Continue reading